In addition to its role in tumor progression and treatment resistance, the involvement of Ack1 in tumor recurrence has been reported in human hepatocellular carcinoma (HCC) [67] and in prostate cancer [68,69]. This evidence concerns the gene TNK2 and hepatocellular carcinoma.